Updated 07:15 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,772.20 -2.38% CL 83.98 -2.36% BTC 64,721.99 -0.26%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,772 −2.38% BTC $64,722 −0.26% VIX 25.46 +11.13% latest tape · as of 07:15 UTC
The Screen · Consumer Cyclical · Footwear & Accessories

Nike, Inc.

NKE · a US exchange · USD · Market cap $57.4B · 77,800 employees

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic and casual footwear, apparel, equipment, accessories, and services for men, women, and kids in North America, Europe, the Middle…

PASS · Titan Ethical · score 77.9
35.85 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price35.85 USD at the 17 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 17 Nov 2026
  • Our regime readMarkup, as of 16 Nov 2026
  • Ethical screenPasses, score 77.9 out of 100
  • OptionsOpen interest leans to puts (put/call 1.09)
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $17.92 to $27.55, base estimate $23.95 (screen dated 2026-11-17).

Current read
Markup ?
Overvalued · screened 2026-11-17
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning political selling, disclosed 2026-10-13
  • Options put/call open interest 1.09, read 2026-11-17
  • Ethical passes the values gate
Price35.85 USD
Fair value23.95
Ethical score77.9/100
Value readOvervaluedas of 17 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup38.67-7.3% to today Accumulation gives way to Markup first Markup read since October
2026-10-25Read Accumulation37.14-3.5% to today Markup gives way to Accumulation first Accumulation read since July
2026-10-18Read Markup37.14-3.5% to today Markdown gives way to Markup first Markup read since August
2026-09-24Read Markdown36.10-0.7% to today ✓Distribution gives way to Markdown after a 10% slide in 3 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Nike, Inc. holds its Markup at $35.85. Consolidating, no directional conviction, held for 70 days.

As held on the ledger · 2026-11-17
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 70 days
Price at the screen$35.85
Valuation18.59 trailing · 25.03 forward price to earnings
Values screenPASS · score 77.9
Beta1.03
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 30.12% Below 33% Interest-bearing debt is just 30.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 4.61% Below 33% Cash held in interest-bearing accounts and securities is 4.6% of assets, under the one-third limit. Pass
Receivables 33.30% Below 49% Money owed to the company is 33.3% of assets, under the 49% limit. Pass
Revenue purity 0.23% Below 5% Only 0.2% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Nike, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when NKE's ethical verdict changes

Today NKE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 17 Nov 2026: it trades above our $23.95 fair value estimate, weak competitive moat.

How a fair value is estimated: discounted cash flow (DCF).

17.92Conservative23.95Base case27.55Growth case 35.85Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 49.7% above the base estimate.

The Street's Range
19.00Street low 34.00Street average 60.00Street high 35.85Price

Third-party analyst targets: 37 covering, consensus Hold. The average target sits −5% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate $23.95, with a range of $17.92 to $27.55, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Nike growth stall leaves valuation stretched

Picture shelves stacked with unsold trainers while shoppers tighten their belts. Nike sits in that spot right now, with sales slipping one percent and a forward multiple of 18.8 times earnings that offers little cushion.

We pass because the shares trade five percent above our fair value and the business shows only a weak moat. Profit margins at seven percent and return on equity of 22 percent look respectable on paper, yet they fail to compensate for the lack of growth in a cyclical consumer market.

Analysts still cluster around a buy rating with targets near 47 dollars, but that optimism often ignores how peak earnings in footwear can quickly reverse. The ethical screen clears, yet the price and outlook do not.

Analysis, not advice.

The fundamentals · plain-English read
Forward P/E25.0xa premium valuation
Trailing P/E18.6xreasonably valued
EPS, trailing2.08
EPS, forward1.55
Revenue growth-4.3%revenue is shrinking
Profit margin6.7%thin but positive margins
Return on equity21.6%an exceptional return on shareholder capital
FCF yield3.08%
Dividend yield3.67%
Debt to equity0.73moderate, manageable leverage
Current ratio2.08comfortably covers its short-term bills
Beta1.03moves a little more than the market
Short interest, float0.11%
52-week range31.97 - 69.14
MoatWEAK
Market cap$57.4B
Employees77,800

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

NKE trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Markup $37.99 -1.6% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-11-08 Markup $38.59 -0.2% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-11-01 Markup · changed $38.67 +4.1% Entry 11

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-10-25 Accumulation · changed $37.14 +0.0% Entry 10

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-10-18 Markup · changed $37.14 +3.9% Entry 9

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-10-11 Markdown $35.75 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-10-02 Markdown $35.75 -1.0% Entry 7

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-09-24 Markdown · changed $36.10 -10.2% Entry 6

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-06 Distribution · changed $40.21 -5.3% Entry 5

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

2026-08-06 Markup · changed $42.45 -1.2% Entry 4

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (33 analysts) rates it buy, with a mean price target of $61. Insiders have been net buyers over the past quarter.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on NKE

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in NKE's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · NKE
DateInsiderTitleTypeSharesValue
2026-04-13 Hill Elliott Pres, CEO Purchase 23,660 $1,000,118
2026-04-13 Hill Elliott Pres, CEO Purchase 23,660 $1,000,000
2026-04-10 Cook Timothy D Dir Purchase 25,000 $1,060,750
2026-04-09 Rogers John W Jr Dir Purchase 4,000 $173,360
2026-04-07 Swan Robert Holmes Dir Purchase 11,781 $500,002
2026-02-12 Leinwand Robert EVP: GC Sale 9,065 $565,021
2025-12-29 Hill Elliott Pres, CEO Purchase 16,388 $1,001,307
2025-12-22 Cook Timothy D Dir Purchase 50,000 $2,948,500
2025-12-22 Swan Robert Holmes Dir Purchase 8,691 $500,080
2025-11-14 Parker Mark G Exec COB Sale 86,078 $5,577,854

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming NKE
DatePoliticianPartyTypeAmount
2026-10-13 Ro Khanna Democrat sell 1K–15K
2026-10-07 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-11 Ro Khanna Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $42.01 +4.9% $0.41 $1,058 +5.8%
2 months $42.24 +4.3% $0.41 $1,053 +5.3%
3 months $53.65 -17.9% $0.41 $829 -17.1%
6 months $66.70 -33.9% $0.82 $673 -32.7%
1 year $62.16 -29.1% $1.63 $735 -26.5%
2 years $91.47 -51.8% $3.20 $517 -48.3%
3 years $99.45 -55.7% $4.65 $490 -51.0%
5 years $121.46 -63.7% $7.17 $422 -57.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NKE does next, these words stay.

Nike, Inc. · NKE · Markup · $35.85
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.